Home > News > S.A. firm licenses stent technology
December 15th, 2005
S.A. firm licenses stent technology
Abstract:
Advanced Bio Prosthetic Surfaces confirmed that it has licensed its stent-making technology for $10 million to Cordis Corp., a Johnson & Johnson company. Using a process known as nanosynthesis, Advanced Bio's researchers have improved the material used to make the stent, which leads to fewer impurities.
Source:
mysanantonio.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||